FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | Sample | Privacy
Related Topics >> Caraco | GMP

Caraco propels Detroit ops comeback

Free Newsletter

FiercePharma Manufacturing provides must-know news and insight on the hardware and software tools used to automate pharmaceutical manufacturing. Sign up today to receive your FREE "insiders only" weekly pharma manufacturing industry briefing.



Tools

GMP consultants working for Caraco have put the finishing touches on a work plan that will let the drugmaker resume manufacturing at its Michigan facilities. The company now awaits FDA approval of the plan, in accordance with its consent decree.

Caraco maintains in its third quarter earnings report that it will pursue the release of some of the inventory seized by U.S. Marshals last June, as reported earlier. Raw materials worth some $8.1 million were opened "solely for the purpose of sampling," during the seizure, says Caraco. The remainder "would be difficult to recondition," the company tells its investors. The company created a $15.9 million reserve last December for this remaining inventory.

Based on its rehab progress to date, Caraco has started recalling some of the 430 employees it let go when manufacturing was halted. The returning employees, it says, are working on manufacturing-restart effort.

- see the Caraco announcement

Related Articles:
Caraco - Top 12 GMP Violations
Deviations attract investor lawyers
GMP deviators keep paying
R&D accepts new assignment
FDA seizure intended to drive "major changes" at Caraco


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Manufacturing Email Newsletter:

More stories about Caraco   GMP